About ASSO International Consulting
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.
Global Contraceptives Strategic Research Report 2022-2028
Global Contraceptives Strategic Research Report 2022-2028 by Regions, by Types, by Application
Hard Copy: 3600 USD
PDF Copy (single user): 3600 USD
Multi User License: 5400 USD
Enterprise wide License: 7200 USD
Pages: 145
Tables and Figures: 166
Published Date: May 2022
Publisher:ASSO International Consulting, Inc.
Contact: Email: sales@assointernationalconsulting.com; contact@assointernationalconsulting.com
Summary
More businesses in the market research, data and insights industry are working toward a step change in their speed, efficiency and product innovation. This has led to a wider demand for more sophisticated and integrated solutions to meet the complex needs of larger established businesses and also newer, hyper-growth and technology-driven companies. ASSO's research report helps decision makers gain insight into market conditions and future trends.
To analyze and research the Contraceptives sales, revenue, consumption, status and forecast.
To focus on the key Contraceptives manufacturers and study the sales, value, market share and development plans in next few years.
To define, describe and forecast the market by type, application.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Global Contraceptives Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The major players in global market include
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Contraceptives in these regions, from 2013 to 2024 (forecast), covering
North America (United States,Canada, Mexico)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
South America (Brazil. Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
On the basis of product, the Contraceptives market is primarily split into
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
On the basis on the end users/applications, this report covers
15–24 years
25–34 years
35–44 years
Above 44 years
Table of Contents
1 Target Product and Background
1.1 Product Overview Contraceptives
1.2 Research Method
1.3 Data Source
1.4 Project Cycle
1.5 Forecast Data Base & Factor
1.6 Macroeconomic Development Trends
1.7 Impact of COVID-19 on the Economy and Contraceptives Industry
1.7.1 Post-COVID-19 era
1.7.2 The Impact of COVID-19 on Contraceptives Industry
2 Manufacturers Competitive Analysis of Major Players
2.1 Competitive Segmentation Analysis of Key Players
2.2 2017-2022 Key Players Sales Volume and Market Positions
2.3 Key Players Revenue and Market Positions
3 Contraceptives Sales Segment Analysis by Type
3.1 Overview
3.1.1 Pills
3.1.2 Injectable
3.1.3 Condoms
3.1.4 Vaginal Rings
3.1.5 IUDs
3.1.6 Subdermal Implants
3.1.7 Others
3.2 2017-2028 Global Contraceptives Sales Volume Segment Analysis by Type
3.3 2017-2028 Global Contraceptives Revenue Segment Analysis by Type
4 Contraceptives Sales Segment Analysis End User
4.1 Introduction
4.1.1 15–24 years
4.1.2 25–34 years
4.1.4 Above 44 years
4.2 2017-2028 Global Contraceptives Sales Volume Segment Analysis by End User
4.3 2017-2028 Global Contraceptives Revenue Segment Analysis by End User
5 Contraceptives Market Analysis, by Region by Country
5.1 Global Contraceptives Market Size and Regional Analysis
5.2 Global Contraceptives Retrospective Market Scenario in Revenue by Region: 2017-2022
5.3 North America Market Size and Regional Analysis
5.3.1 North America Sales by Country
5.3.2 North America Contraceptives Revenue by Country
5.4 Europe Market Size and Regional Analysis
5.4.1 Europe Contraceptives Sales by Country
5.4.2 Europe Contraceptives Revenue by Country
5.5 Asia Pacific Market Size and Regional Analysis
5.5.1 Asia Pacific Contraceptives Sales by Region
5.5.2 Asia Pacific Contraceptives Revenue by Region
5.6 South America Market Size and Regional Analysis
5.6.1 South America Contraceptives Sales by Country
5.6.2 South America Contraceptives Revenue by Country
5.7 Middle East and Africa Market Size and Regional Analysis
5.7.1 Middle East and Africa Contraceptives Sales by Country
5.7.2 Middle East and Africa Contraceptives Revenue by Country
6 Contraceptives SWOT and Driving Factor Analysis
6.1 SWOT Analysis
6.2 Marketing Strategy
6.3 Technology Driven Market
6.4 Contraceptives Growth Drivers
6.5 Contraceptives Market Challenges
6.6 Contraceptives Market Restraints
7 ContraceptivesRaw Material Supply and Industry Chain Analysis
7.1 Contraceptives Key Raw Material Supply
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Contraceptives Industrial Chain Analysis and Reconstruction
8 Global Contraceptives Major Manufacturers Analysis
8.1 Bayer AG
8.1.1 Bayer AG Corporate Outline
8.1.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.1.3 Bayer AG Contraceptives Key Product Overview
8.1.4 Contraceptives Key Product Overview
8.1.5 Bayer AG Business Segmentation SWOT Analysis
8.2 Pfizer, Inc
8.2.1 Pfizer, Inc Corporate Outline
8.2.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.2.3 Pfizer, Inc Contraceptives Key Product Overview
8.2.4 Contraceptives Key Product Overview
8.2.15Pfizer, Inc Business Segmentation SWOT Analysis
8.3 Teva Pharmaceutical Industries Ltd
8.3.1 Teva Pharmaceutical Industries Ltd Corporate Outline
8.3.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.3.3 Huazhong Contraceptives Key Product Overview
8.3.4 Contraceptives Key Product Overview
8.3.5 Teva Pharmaceutical Industries Ltd Business Segmentation SWOT Analysis
8.4 Merck & Co., Inc
8.4.1 Merck & Co., Inc Corporate Outline
8.4.1 Merck & Co., Inc Corporate Outline
8.4.3 The Cooper Companies Contraceptives Key Product Overview
8.4.4 Contraceptives Key Product Overview
8.4.5 Merck & Co., Inc Business Segmentation SWOT Analysis
8.5 Actavis, Inc.
8.5.1 Actavis, Inc. Corporate Outline
8.5.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.5.3 Contraceptives Key Product Overview
8.5.4 Contraceptives Key Product Overview
8.5.5 Actavis, Inc. Business Segmentation SWOT Analysis
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Corporate Outline
8.6.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.6.3 Contraceptives Key Product Overview
8.6.4 Contraceptives Key Product Overview
8.6.5 Johnson & Johnson Business Segmentation SWOT Analysis
8.7 Gedeon Richter
8.7.1 Gedeon Richter Corporate Outline
8.7.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.7.3 Contraceptives Key Product Overview
8.7.4 Contraceptives Key Product Overview
8.7.5 Gedeon Richter Business Segmentation SWOT Analysis
8.8 Novo Nordisk A/S
8.8.1 Novo Nordisk A/S Corporate Outline
8.8.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.8.3 Contraceptives Key Product Overview
8.8.4 Contraceptives Key Product Overview
8.8.5 Novo Nordisk A/S Business Segmentation SWOT Analysis
8.9 ZiZhu
8.9.1 ZiZhu Corporate Outline
8.9.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.9.3 Contraceptives Key Product Overview
8.9.4 Contraceptives Key Product Overview
8.9.5 ZiZhu Business Segmentation SWOT Analysis
8.10 Baijingyu
8.10.1 Baijingyu Corporate Outline
8.10.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.10.3 Contraceptives Key Product Overview
8.10.4 Contraceptives Key Product Overview
8.10.5 Baijingyu Business Segmentation SWOT Analysis
8.11 Huazhong
8.12 Sine
8.13 Reckitt
8.14 AbbVie
8.15 Church & Dwight
8.16 The Cooper Companies
8.17 TherapeuticsMD
8.18 Afaxys
8.19 Mithra Pharmaceuticals
9 Contraceptives Report Conclusion and Strategy
10 Appendix
10.1 Order and After-sales Service
10.2 Author List
10.3 Disclaimer
List of Tables
Table 1. Competitive Segmentation Analysis of Key Players
Table 2. 2017-2022 Key Players Sales Volume and Market Positions (K Units)
Table 3. 2017-2022 Key Players Revenue and Market Positions (US$ Million)
Table 4. Global Contraceptives Market Size Comparison by Type (2022-2028)
Table 5. Analysis of the Distribution of Main Players' Product Types
Table 6. 2017-2028 Global Contraceptives Sales Volume Segment Analysis by Type (K Units)
Table 7. 2017-2028 Global Contraceptives Sales Volume Share by Type
Table 8. 2017-2028 Global Contraceptives Revenue Segment Analysis by Type (US$ Million)
Table 9. Global Contraceptives Revenue Share by Type (2017-2022)
Table 10. Competitive Segmentation Analysis of Key Players
Table 11. Global Contraceptives Market Size Comparison by End User (2022-2028)
Table 12. 2017-2028 Global Contraceptives Sales Volume Segment Analysis by End User (K Units)
Table 13. 2017-2028 Global Contraceptives Sales Volume Share by End User
Table 14. 2017-2028 Global Contraceptives Revenue Segment Analysis by End User (US$ Million)
Table 15. Global Contraceptives Revenue Share by End User (2017-2022)
Table 16. 2017-2028 Global Segment: Contraceptives Sales Volume Market, by Region (K Units)
Table 17. 2017-2028 Global Segment: Contraceptives Sales Volume Market Share, by Region
Table 18. 2017-2028 Global Segment: Contraceptives Revenue Market, by Region (US$ Million)
Table 19. 2017-2028 Global Segment: Contraceptives Revenue Market Share, by Region
Table 20. 2017-2022E North America Segment: Contraceptives Sales Volume Market, by Country (K Units)
Table 21. 2017-2022E North America Segment: Contraceptives Revenue Market, by Country (US$ Million)
Table 22. 2017-2022E Europe Segment: Contraceptives Sales Volume Market, by Country (K Units)
Table 23. 2017-2022E Europe Segment: Contraceptives Revenue Market, by Country (US$ Million)
Table 24. 2017-2022E Asia Pacific Segment: Contraceptives Sales Volume Market, by Country (K Units)
Table 25. 2017-2022E Asia Pacific Segment: Contraceptives Revenue Market, by Country (US$ Million)
Table 26. 2017-2022E South America Segment: Contraceptives Sales Volume Market, by Country (K Units)
Table 27. 2017-2022E South America Segment: Contraceptives Revenue Market, by Country (US$ Million)
Table 28. 2017-2022E Middle East and Africa Segment: Contraceptives Sales Volume Market, by Country (K Units)
Table 29. Middle East and Africa Contraceptives Revenue Market Share in 2021, by Country (% Share)
Table 30. 2017-2022E Middle East and Africa Segment: Contraceptives Revenue Market, by Country (US$ Million)
Table 31. Contraceptives Growth Drivers
Table 32. Key Suppliers of Raw Materials
Table 33. Bayer AG Corporate Outline
Table 34. Bayer AG Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 35. Bayer AG Key Product Overview
Table 36. Pfizer, Inc Corporate Outline
Table 37. Pfizer, Inc Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 38. Pfizer, Inc Key Product Overview
Table 39. Teva Pharmaceutical Industries Ltd Corporate Outline
Table 40. Teva Pharmaceutical Industries Ltd Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 41. Teva Pharmaceutical Industries Ltd Key Product Overview
Table 42. Merck & Co., Inc Corporate Outline
Table 43. Merck & Co., Inc Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 44. Merck & Co., Inc Key Product Overview
Table 45. Actavis, Inc. Corporate Outline
Table 46. Actavis, Inc. Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 47. Actavis, Inc. Key Product Overview
Table 48. Johnson & Johnson Corporate Outline
Table 49. Johnson & Johnson Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 50. Johnson & Johnson Key Product Overview
Table 51. Gedeon Richter Corporate Outline
Table 52. Gedeon Richter Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 53. Gedeon Richter Key Product Overview
Table 54. Novo Nordisk A/S Corporate Outline
Table 55. Novo Nordisk A/S Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 56. Novo Nordisk A/S Key Product Overview
Table 57. ZiZhu Corporate Outline
Table 58. ZiZhu Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 59. ZiZhu Key Product Overview
Table 60. Baijingyu Corporate Outline
Table 61. Baijingyu Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 62. Baijingyu Key Product Overview
Table 63. Huazhong Corporate Outline
Table 64. Huazhong Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 65. Huazhong Key Product Overview
Table 66. Sine Corporate Outline
Table 67. Sine Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 68. Sine Key Product Overview
Table 69. Reckitt Corporate Outline
Table 70. Reckitt Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 71. Reckitt Key Product Overview
Table 72. AbbVie Corporate Outline
Table 73. AbbVie Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 74. AbbVie Key Product Overview
Table 75. Church & Dwight Corporate Outline
Table 76. Church & Dwight Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 77. Church & Dwight Key Product Overview
Table 78. The Cooper Companies Corporate Outline
Table 79. The Cooper Companies Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 80. The Cooper Companies Key Product Overview
Table 81. TherapeuticsMD Corporate Outline
Table 82. TherapeuticsMD Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 83. TherapeuticsMD Key Product Overview
Table 84. Afaxys Corporate Outline
Table 85. Afaxys Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 86. Afaxys Key Product Overview
Table 87. Mithra Pharmaceuticals Corporate Outline
Table 88. Mithra Pharmaceuticals Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 89. Mithra Pharmaceuticals Key Product Overview
List of Tables and Figures
Figure 1. Product Picture of Contraceptives
Figure 2. Proportion of GDP of Major Countries in the World in 2018
Figure 3. Figure Projected Growth Profiles for Major Economies – Regression to the Mean
Figure 4. Figure Key Economies’ Share of World GDP in PPP Terms
Figure 5. Global Economic Forecast in 2050
Figure 6. Global GDP Forecast by Region to 2050
Figure 7. Climate Change Impact on Level of GDP in 2050
Figure 8. Economic Impact of COVID-19 on Major Economies in 2021
Figure 9. IMF's Latest Global Economic Forecast by 2022Q1
Figure 10. Comparative Analysis of the Direct Impact of COVID-19 on the Industry (US$ Million)
Figure 11. Characteristics of the Impact of COVID-19 on the Industry
Figure 12. Key Players Revenue Volume Share in 2021
Figure 13. Global Contraceptives Revenue Share by Manufacturers in 2021
Figure 14. Market Size Share Comparison by End User
Figure 15. Global Contraceptives Market Size by Region in 2021
Figure 16. Global Contraceptives Market Size by Region: 2017 VS 2021 VS 2028
Figure 17. Global Contraceptives Market Size 2017-2028 (US$ Million)
Figure 18. Global Contraceptives Market Size 2017-2028 (US$ Million)
Figure 19. 2017-2028 Global Segment: Contraceptives Sales Volume Market Share, by Region
Figure 20. 2017-2028 Global Segment: Contraceptives Revenue Market Share, by Region
Figure 21. North America Contraceptives Key Player Distribution Analysis
Figure 22. North America Contraceptives Revenue Market Share in 2021, by Country (% Share)
Figure 23. Europe Contraceptives Key Player Distribution Analysis
Figure 24. Europe Contraceptives Revenue Market Share in 2021, by Country (% Share)
Figure 25. Asia Pacific Contraceptives Key Player Distribution Analysis
Figure 26. Asia Pacific Contraceptives Revenue Market Share in 2021, by Country (% Share)
Figure 27. South America Contraceptives Key Player Distribution Analysis
Figure 28. South America Contraceptives Revenue Market Share in 2021, by Country (% Share)
Figure 29. Middle East and Africa Contraceptives Key Player Distribution Analysis
Figure 30. Contraceptives Industry SWOT Analysis
Figure 31. Figure Marketing Strategy
Figure 32. Contraceptives Technology Development Trend
Figure 33. Global Stars: The Most Innovative Countries, Ranked by Income Group in 2019
Figure 34. Leading countries by gross research and development (R&D) expenditure worldwide in 2021(in billion U.S. dollars)
Figure 35. Contraceptives Industrial Chain Analysis
Figure 36. FDI, trade, GDP and GVC trends, 1990–2019
Figure 37. World Carbon Dioxide Emissions from 2009 to 2019, by region (in Million Metric Tons of Carbon Dioxide)
Figure 38. Global Energy Structure Evolution Structure
Figure 39. The Evolution of Global Road Vehicles to 2050
Figure 40. Bayer AG SWOT Analysis
Figure 41. Pfizer, Inc SWOT Analysis
Figure 42. Teva Pharmaceutical Industries Ltd SWOT Analysis
Figure 43. Merck & Co., Inc SWOT Analysis
Figure 44. Actavis, Inc. SWOT Analysis
Figure 45. Johnson & Johnson SWOT Analysis
Figure 46. Gedeon Richter SWOT Analysis
Figure 47. Novo Nordisk A/S SWOT Analysis
Figure 48. ZiZhu SWOT Analysis
Figure 49. Baijingyu SWOT Analysis
Figure 50. Huazhong SWOT Analysis
Figure 51. Sine SWOT Analysis
Figure 52. Reckitt SWOT Analysis
Figure 53. AbbVie SWOT Analysis
Figure 54. Church & Dwight SWOT Analysis
Figure 55. The Cooper Companies SWOT Analysis
Figure 56. TherapeuticsMD SWOT Analysis
Figure 57. Afaxys SWOT Analysis
Figure 58. Mithra Pharmaceuticals SWOT Analysis
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning
– Allen King
Leave a comment
All fields marked with an asterisk (*) are required